Virtu Financial LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$3
-40.0%
16,437
+56.7%
0.00%
-100.0%
Q4 2022$5
-100.0%
10,491
-37.1%
0.00%0.0%
Q1 2022$20,000
-50.0%
16,676
-8.0%
0.00%
-80.0%
Q2 2020$40,000
-24.5%
18,129
-41.8%
0.01%
+25.0%
Q3 2019$53,000
+140.9%
31,124
+185.8%
0.00%
+300.0%
Q2 2019$22,000
-84.6%
10,892
-72.7%
0.00%
-87.5%
Q1 2019$143,000
+146.6%
39,864
+33.8%
0.01%
+166.7%
Q2 2018$58,00029,8000.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 4,103,098$2,585,0003.26%
Omnia Family Wealth, LLC 782,372$493,0000.40%
ARMISTICE CAPITAL, LLC 4,290,000$2,703,0000.05%
Bryn Mawr Capital Management, LLC 100,000$63,0000.02%
NEA Management Company, LLC 452,167$285,0000.01%
Hikari Power Ltd 130,821$82,0000.01%
Truvestments Capital LLC 1,621$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$19,0000.00%
MILLENNIUM MANAGEMENT LLC 37,544$24,0000.00%
Renaissance Technologies 40,050$25,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders